The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
BriaCell Therapeutics Corp. quarterly Current Ratio history and growth rate from Q1 2023 to Q2 2024.
BriaCell Therapeutics Corp. Current Ratio for the quarter ending July 31, 2024 was 205 %, a 92.3% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period
Value
YoY Chg
Change %
Date
Q2 2024
205
-2.46K
-92.3%
Jul 31, 2024
Q1 2024
463
-3.17K
-87.2%
Apr 30, 2024
Q4 2023
1.06K
Jan 31, 2024
Q3 2023
2.22K
Oct 31, 2023
Q2 2023
2.66K
Jul 31, 2023
Q1 2023
3.63K
Apr 30, 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.